What's in Ente Ospedaliero Ospedali Galliera's pipeline?

Ente Ospedaliero Ospedali Galliera has 5 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 2 in Phase 1.

Which companies overlap with Ente Ospedaliero Ospedali Galliera's portfolio?

Top competitors by shared drug class: Bristol-Myers Squibb, Daewoong Pharmaceutical Co. LTD., Elcelyx Therapeutics, Inc., Eli Lilly and Company, First Affiliated Hospital of Wenzhou Medical University.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/ente-ospedaliero-ospedali-galliera.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Ente Ospedaliero Ospedali Galliera — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ente Ospedaliero Ospedali Galliera pipeline: 1 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 1 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
MET	MET	marketed	Biguanide	AMP-activated protein kinase (AMPK) / mitochondrial complex I	Endocrinology / Diabetes
Neridronate	Neridronate	phase 3		Farnesyl pyrophosphate synthase	Bone

Therapeutic area mix

Bone · 1
Endocrinology / Diabetes · 1
Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bristol-Myers Squibb · 1 shared drug class
Daewoong Pharmaceutical Co. LTD. · 1 shared drug class
Elcelyx Therapeutics, Inc. · 1 shared drug class
Eli Lilly and Company · 1 shared drug class
First Affiliated Hospital of Wenzhou Medical University · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Janssen Research & Development, LLC · 1 shared drug class
AstraZeneca · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Ente Ospedaliero Ospedali Galliera:

Cite this brief

Drug Landscape (2026). Ente Ospedaliero Ospedali Galliera — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ente-ospedaliero-ospedali-galliera. Accessed 2026-05-17.